Skip to main content
Home
About the fund
The Team
Portfolio
News & Insights
Information
How to apply
FAQs
Contact
Search
You are here
Home
»
News & Insights
News & Insights
Reset
Sector
All
Life Sciences
Physical Sciences
News
UCLTF nominated for 'Investment Unit of the Year'
We are delighted to announce that the UCL Technology Fund has been nominated for Investment Unit of the Year by Global University...
April 30, 2019
Investment
Odin Vision scales up its pioneering cancer detection technology
Innovative medtech company Odin Vision is to scale up its pioneering cancer detection technology thanks to an investment round...
April 30, 2019
Investment
Astroscreen raises $1m to detect social media manipulation
UK-based start-up Astroscreen has secured $1M in initial funding to progress its pioneering technology which identifies carriers...
April 18, 2019
News
Data Supports Achievement of Proof-of-Concept Milestone for OTL-300
Orchard Therapeutics has announced the achievement of clinical proof-of-concept based on data from the trial of OTL-300, for the...
April 16, 2019
News
Orchard Therapeutics achieves 100% survival rate during trial treatment for ADA-SCID
Orchard Therapeutics, a commercial-stage biopharmaceutical company, presented their two-year follow-up data in 20 patients from...
February 28, 2019
News
Hazy included in Forbes '15 Machine Learning Companies To Watch In Europe'
Hazy has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch.
December 03, 2018
Investment
IGEM Therapeutics Announces Final Close of £5m Series A Financing Round
New investors Alsa Holdings and UCL Technology Fund join Epidarex Capital Proceeds will allow IGEM to continue development of IgE...
November 30, 2018
News
Orchard Therapeutics announces closing of $225 Million Initial Public Offering
Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through...
November 05, 2018
Investment
UCL spin-out Hazy adds $1.8 million in seed funding
Hazy, the London-based AI company enabling ethical, effortless and GDPR-compliant data sharing for responsible businesses, has...
August 01, 2018
News
UCL Technology Fund investment MeiraGTx raises $75m at IPO
MeiraGTx is its first UCLTF investment to IPO
July 24, 2018
Exit
Bloomsbury AI joins the Facebook Team in London
UCL Technology Fund is very proud to have backed Bloomsbury AI and we are delighted that they are joining the Facebook team.
July 04, 2018
Investment
Matr raises £4.75 million for AI teaching platform
Matr, the online teaching platform, has announced it has closed a £4.75 million Series A investment round led by the UCL...
June 21, 2018
News
Freeline secures over £88 million of funding
Freeline Therapeutics announces today that it has raised over £88 million of new capital in a Series B financing round
June 19, 2018
Insights
UCL Technology Fund Showcase 2018
The inaugural UCL Technology Fund Showcase, held at Digital Catapult, brought together two years of investing in world-leading...
May 24, 2018
Investment
UCL Technology Fund invests in cell therapy company Glialign
The UCL Technology Fund, UK Innovation & Science Seed Fund, alongside support from Innovate UK, have invested in UCL spinout...
May 03, 2018
Investment
UCL Technology Fund and ParkWalk invest in adtech machine learning company MediaGamma
The UCL Technology Fund has invested in MediaGamma, the predictive analytics software company, as part of a £2m round in...
February 26, 2018
Investment
UCL Technology Fund has approved investment of up to £1m in the development of a gene therapy for p47-CGD
The UCL Technology Fund has approved an investment of up to £1m to support the development of a gene therapy for p47phox-...
April 11, 2017
Investment
UCLTF fund drug development platform Canbex for the treatment of multiple sclerosis
Canbex was established to develop the VSN compound series, a drug development platform with potential applications in a wide...
January 16, 2017
News
Orchard Therapeutics launches with £21-million series A funding round
Orchard Therapeutics has secured £21-million in Series A financing led by F-Prime with UCLTF. Orchard Therapeutics is a...
May 03, 2016
News
Albion to Manage the UCL Technology Fund
Albion Capital, one of the largest independent venture capital investors in the UK is to manage and administer the newly launched...
January 18, 2016
